CV1 A Cost-Utility Analysis of Prophylactic Therapy for Venous Thromboembolism with Dabigatran Etexilate or Enoxaparin
Nov 1, 2011, 00:00 AM
10.1016/j.jval.2011.08.1514
https://www.valueinhealthjournal.com/article/S1098-3015(11)03076-2/fulltext
Section Title :
Cardiovascular Disorders Outcomes Research
Section Order :
1467
First Page :
A535
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)03076-2&doi=10.1016/j.jval.2011.08.1514